Ocean Biomedical Stock Performance
| OCEA Stock | 0 0 166.67% |
Ocean Biomedical holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of -11.82, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ocean Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, Ocean Biomedical is expected to outperform it. Use Ocean Biomedical coefficient of variation, sortino ratio, potential upside, as well as the relationship between the jensen alpha and maximum drawdown , to analyze future returns on Ocean Biomedical.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ocean Biomedical are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, Ocean Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Ocean |
Ocean Biomedical Relative Risk vs. Return Landscape
If you would invest 0.20 in Ocean Biomedical on October 29, 2025 and sell it today you would lose (0.17) from holding Ocean Biomedical or give up 85.0% of portfolio value over 90 days. Ocean Biomedical is currently generating 17.2005% in daily expected returns and assumes 90.6466% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Ocean, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ocean Biomedical Target Price Odds to finish over Current Price
The tendency of Ocean Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 24.53 |
Based on a normal probability distribution, the odds of Ocean Biomedical to move above the current price in 90 days from now is about 24.53 (This Ocean Biomedical probability density function shows the probability of Ocean Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Ocean Biomedical has a beta of -11.82. This indicates as returns on its benchmark rise, returns on holding Ocean Biomedical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Ocean Biomedical is expected to outperform its benchmark. In addition to that Ocean Biomedical has an alpha of 22.2608, implying that it can generate a 22.26 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ocean Biomedical Price Density |
| Price |
Predictive Modules for Ocean Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocean Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocean Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocean Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ocean Biomedical is not an exception. The market had few large corrections towards the Ocean Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ocean Biomedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ocean Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 22.26 | |
β | Beta against Dow Jones | -11.82 | |
σ | Overall volatility | 0.0007 | |
Ir | Information ratio | 0.24 |
Ocean Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocean Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocean Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| About 14.0% of the company outstanding shares are owned by corporate insiders |
Ocean Biomedical Fundamentals Growth
Ocean Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ocean Biomedical, and Ocean Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ocean Pink Sheet performance.
| Return On Asset | -0.74 | |||
| Current Valuation | 18.14 M | |||
| Shares Outstanding | 166.01 M | |||
| Price To Book | 100.67 X | |||
| EBITDA | (957.74 K) | |||
| Total Debt | 16.3 M | |||
| Book Value Per Share | (2.80) X | |||
| Cash Flow From Operations | (4.18 M) | |||
| Earnings Per Share | (0.34) X | |||
| Total Asset | 902 K | |||
| Retained Earnings | (205.53 M) | |||
About Ocean Biomedical Performance
By analyzing Ocean Biomedical's fundamental ratios, stakeholders can gain valuable insights into Ocean Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ocean Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ocean Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Ocean Biomedical performance evaluation
Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| About 14.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Ocean Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ocean Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Ocean Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ocean Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ocean Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ocean Biomedical's pink sheet. These opinions can provide insight into Ocean Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ocean Pink Sheet analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |